Rybelsus 14mg Tablet

Description

Rybelsus 14mg tablet is an oral GLP-1 receptor agonist containing semaglutide, designed for adults seeking maximum blood sugar control and sustained weight reduction. It’s the final step in the Rybelsus dosage progression (3mg → 7mg → 14mg), offering full GLP-1 efficacy in a convenient tablet form.

This innovative therapy works by mimicking the GLP-1 hormone, helping the body naturally regulate insulin release, suppress appetite, and slow digestion for more stable glucose levels.

Key Features:

• Highest available oral GLP-1 dose (14mg semaglutide)

• Proven to lower A1C and support significant weight loss (NEJM Clinical Study)

• Non-injectable option for long-term treatment

• Once-daily dosing with simple administration

• Backed by FDA approval and global clinical data

Usage Instructions:

• Take one 14mg tablet daily on an empty stomach

• Swallow with a small sip of water (no more than 4 oz / 120ml)

• Wait 30 minutes before eating or drinking

• Only begin 14mg dosage after completing 3mg and 7mg phases under medical guidance

Side Effects:

Common side effects include mild nausea or bloating, which usually reduce over time. For complete safety and dosing information, see the FDA Rybelsus Label.

Storage Instructions:

• Store at 68°F–77°F (20°C–25°C)

• Keep in original packaging to protect from moisture and light

• Do not freeze or refrigerate